Dialog Box

Research using ICGC Data

ICGC Controlled Data Users Quarter 3, 2026 

The register of every research project currently approved to access ICGC controlled data. 


Between 3 June and 30 September 2026, the ICGC Data Access Compliance Office (DACO) approved 35 new research projects for access to ICGC controlled data. The projects come from 15 countries.

The United States leads with 11 projects, followed by China with 4 and the United Kingdom with 3. Australia, Brazil, Israel, Japan and the United Arab Emirates each have one approved project.

Pancreatic cancer features in five projects and biliary tract cancers in four. Other projects cover paediatric cancers including medulloblastoma, liver, colorectal and gastrointestinal cancers, and sarcoma.

This brings the total for 2026 to 89 approved projects across 23 countries.

DACO publishes every approved project to show research participants and the wider community how ICGC data is used. Approvals run for two years and are assessed against the ICGC Policies and Guidelines. 

See the full list of approved controlled data users

Contact us with any questions at admin@icgc-argo.org



About DACO

Over 15 years, the DACO has supported close to 6,000 research projects in 38 countries. DACO provides a single compliance pathway, consolidating oversight across dozens of institutions and jurisdictions. It maintains rigorous ethical, legal, and procedural standards that enable responsible, cross-border data sharing while preserving the confidentiality of research participants, supporting efficient and trusted collaboration in global cancer genomics research. 

APPLY FOR ACCESSBROWSE THE DATA

29 October 2026
Category: News
Tags:
Donate